About this trial
The aim of the planned study project is to assess the current situation regarding the treatment of patients with stroke. Specifically, various treatment strategies are to be associated and correlated with clinical endpoints, mortality or functional outcome in order to generate arguments for or against individual aspects of therapy. The focus will be on unresolved treatment approaches in acute therapy (e.g. periprocedural management, such as blood pressure, blood glucose, temperature, or airway management, during recanalizing therapies) as well as in secondary prevention on the stroke unit or intensive care unit, such as starting point, mode, and dosage of antithrombotic therapies.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age above 18
Patient admitted for acute stroke (Stroke Unit or Intensive Care Unit)
Informed Consent
Disqualifiers
Inclusion criteria not met
Trial population
All patients admitted for acute stroke
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Modified Rankin-scale after 3 months
Funtional Outcome measured by modified Rankin-scale. The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.
Modified Rankin-scale after 12 months
Funtional Outcome measured by modified Rankin-scale. The scale runs from 0-6, running from perfect health without symptoms to death. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.
Secondary outcomes
Intrahospital Mortality
Number of patients that died during initial hospital phase.
Short-term and long-term mortality
Number of patients that died over the course of 3 and 12 months
New stroke
Number of patients with new stroke.
Other outcomes
Recurring pneumonia during follow-up
Number of patients with recurring pneumonia.
Epilepsy
Number of patients with occurence of epilepsy and its treatment
Cognitive decline
Number of patients with cognitive decline as measured with the Montreal Cognitive Assessment
Tracheostomy
Number of patients with need for longterm tracheostomy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.